To include your compound in the COVID-19 Resource Center, submit it here.

Perseverance worth $100 million

Early-stage investors haven't lost their interest in biotechnology and health care, as evidenced by the $100 million life sciences fund just closed by Schroder Ventures.

Raising the money wasn't

Read the full 286 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE